Manage Your Liver
Q:

What is liver cancer?

A:

There are two types of liver cancer, primary and secondary. Primary liver cancer is cancer that begins in liver cells. The most common form of primary liver cancer in adults is hepatocellular carcinoma (HCC), which begins in the main type of liver cell called the hepatocyte. Secondary or metastatic liver cancer is cancer that has started in another part of the body and has spread to the liver.

The information here is about primary liver cancer.

 

Risk Factors

The exact causes of primary liver cancer are not known, but some factors can increase the risk:

  • Cirrhosis
  • Nonalcoholic fatty liver disease (NAFLD)
  • Chronic hepatitis B or C infection
  • Diabetes
  • Sustained excessive alcohol consumption
  • Obesity

 

Signs and Symptoms

  • Upper abdominal pain
  • Nausea
  • Loss of appetite
  • Jaundice (yellowing of skin or whites of eyes)
  • Weight loss
  • Swelling in the abdomen
  • Fatigue
  • Itching

 

Diagnosis

A number of tests and procedures can be used to diagnose liver cancer:

Imaging tests such as ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI) produce images of the inside of the body
Biopsy is often the only certain way to confirm that liver cancer is present. It can also tell whether the liver cancer is primary or secondary

 

Liver Cancer Treatment
Treatment varies according to a few important factors: type of the liver cancer, stage of the cancer, health of the rest of the liver and overall health. Treatment options may include:

  • Thermal ablation
  • Tumor embolization
  • Radiation therapy
  • Targeted therapy
  • Chemotherapy

Sometimes, doctors may recommend a combination of more than one of these treatments.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Cancer is a leading cause of morbidity and mortality in the United States and results in a high economic burden. A recent research published by The JAMA Network has reveal that cancer mortality declined overall in the United States between 1980 and 2014. And the number of deaths for nearly all forms of cancer has decreased significantly, but not for liver cancer, kidney cancer and non-Hodgkin lymphoma (NHL) cancer.   Deaths due to NHL and kidney cancer remained the sa
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us